This award supports new and pioneering research ideas and pilot studies of high scientific risk to stimulate and develop the early detection field.
Timelines
Applications are reviewed twice per year. Upcoming application deadline: 26 March 2026
Funding period
Up to one year
Funding amount
Up to £100k
The applicant
You can apply to this award if you’re a scientist, clinician or healthcare worker based in a UK university, medical school, hospital or research institution.
You can hold this award if you’ve had funding from us before.
To achieve our goal of developing the early detection and diagnosis field, we encourage applications from a broad range of fields, such as:
biomedicine
engineering
physics
statistics
mathematics
chemistry
informatics
computer and data sciences
You don’t have to have previous experience within cancer research, but a clear link between the proposed project, early detection or diagnosis of cancer and a vision towards future clinical implementation is required.
Career stage
We welcome researchers from all career stages to apply. In cases where an early career researcher is lead or joint lead applicant, we would strongly recommend including at least one established researcher as co-applicant for mentorship.
We outline how we define career stages in our competency framework.
Collaborations
We encourage applications from research teams, which can be located across different institutions in the UK. Supporting roles from international and commercial organisations may also be included as co-investigators and collaborators.
The host institution
Your host institution must approve your application before the submission deadline, so please ensure you are in contact with your institution’s administrative staff in advance. Host institutions must ensure they can provide sufficient space and resources for the proposed research.
If you receive core funding from one of our institutes (including the Francis Crick Institute), you may apply as a joint lead applicant with a researcher based outside the institute. However, you should explain why you require extra support in addition to the funding you receive from the institute.
You will need to distinguish your core funded research from the research in your proposal and demonstrate your ability to manage both programmes of work. If this applies to you, you must contact us before submitting your application.
Applications to other funding bodies
You can submit applications for the same project to different funding bodies, including us. However, if successful, you may only accept one award. If applicable, please inform us and disclose this under the 'Other Funding' section of your application.
Flexible working arrangements
Career breaks (due to personal circumstances), part-time working and changes in discipline will be taken into consideration by our panels and committees to make appropriate adjustments when assessing your record of outputs, research achievements and career progression.
You can apply on a part-time or flexible working basis if this fits with the needs of your host institution and they approve your request.
If you’d like to apply on a part-time basis, please contact us before starting your application to discuss your proposed parameters for the award and how to include the part-time request in your application.
Successful CRUK applications tend to have the following strengths:
✔ 1. Clear Scientific Merit & Innovation
Applications must articulate a compelling research question with robust methodology and novelty. Innovative approaches that could lead to substantial advances in cancer biology, therapy, imaging, prevention, or data science are favoured.
✔ 2. Relevance to Cancer and Translational Potential
Projects should clearly relate to understanding, preventing or treating cancer. Translational impact — e.g., potential to improve diagnosis, treatment or patient outcomes — is particularly valued in clinical and translational schemes.
✔ 3. Strong Applicant Track Record & Environment
Reviewers assess the investigator’s prior achievements, training, and evidence of independence (especially for fellowships), as well as institutional support and access to resources necessary to complete the project successfully.
✔ 4. Feasibility & Deliverables
CRUK reviewers look for realistic timelines, achievable milestones and a clear plan for measuring outcomes within the funding period. Strong proposals use preliminary data effectively to support feasibility.
✔ 5. Collaboration & Multidisciplinarity (when appropriate)
Collaborative or multidisciplinary plans — especially those integrating physical sciences, engineering, computational/data science or clinical networks — are often competitive in relevant schemes like Multidisciplinary Project Awards.
✔ 6. Engagement with Funding Mechanisms
Understanding the specific aims and review priorities of each scheme (e.g., translational emphasis for clinical schemes) and carefully aligning the application narrative with these priorities improves chances of success.
✔ Register in Flexi-Grant early and ensure host institution endorsement before submission. Cancer Research UK Flexigrant
✔ Align with CRUK’s mission — link research goals to cancer outcomes and patient benefit. Cancer Research UK
✔ Budget judiciously — justify requested resources relative to deliverables.
✔ Provide robust preliminary data where possible to strengthen feasibility arguments.
✔ Demonstrate institutional support and mentorship for fellowships.
| Category | Examples of Schemes | Focus |
|---|---|---|
| Fellowships | Career Development; Clinical Future Leaders | Research independence, leadership |
| Clinical/Translational | Clinical Research Funding Scheme | Patient-oriented and translational studies |
| Collaborative/Project Grants | Multidisciplinary Project Award | Collaborative cancer research |
| International Fellowships | AACR–CRUK Transatlantic | Postdoc international collaborations |
| Training Fellowships | CRTF (centre-specific) | PhD training for clinicians |
Our core eligibility criteria are outlined below.
We recommend that you contact us for an informal and confidential discussion of your proposal prior to submitting your application. We’ll advise on your eligibility and provide guidance on submitting your application.
Sponsor Institute/Organizations: Cancer Research UK
Sponsor Type: Corporate/Non-Profit
Address: 2 Redman Place, London, E20 1JQ.
Affiliation Disclaimer: Trialect operates independently and is not affiliated with, endorsed by, or supported by any sponsors or organizations posting on the GrantsBoard platform. As an independent aggregator of publicly available funding opportunities, Trialect provides equal access to information for all users without endorsing any specific funding source, content, organization, or sponsor. Trialect assumes no responsibility for the content posted by sponsors or third parties.
Subscription Disclaimer: Upon logging into Trialect, you may choose to SUBSCRIBE to GrantsBoard for timely notifications of funding opportunities and to access exclusive benefits, such as priority alerts, reminders, personalized recommendations, and additional application support. However, users are advised to contact sponsors directly for any questions and are not required to subscribe to engage with funding opportunities.
Content Ownership and Copyright Disclaimer: Trialect respects the intellectual property rights of all organizations and individuals. All content posted on GrantsBoard is provided solely for informational purposes and remains the property of the original owners. Trialect does not claim ownership of, nor does it have any proprietary interest in, content provided by third-party sponsors. Users are encouraged to verify content and ownership directly with the posting sponsor.
Fair Use Disclaimer: The information and content available on GrantsBoard are compiled from publicly accessible sources in alignment with fair use principles under U.S. copyright law. Trialect serves as an aggregator of this content, offering it to users in good faith and with the understanding that it is available for public dissemination. Any organization or individual who believes their intellectual property rights have been violated is encouraged to contact us for prompt resolution.
Third-Party Posting Responsibility Disclaimer: Trialect is a neutral platform that allows third-party sponsors to post funding opportunities for informational purposes only. Sponsors are solely responsible for ensuring that their postings comply with copyright, trademark, and other intellectual property laws. Trialect assumes no liability for any copyright or intellectual property infringements in third-party content and will take appropriate action to address any substantiated claims.
Accuracy and Verification Disclaimer: Trialect makes no warranties regarding the accuracy, completeness, or reliability of the information provided by sponsors. Users are advised to verify the details of any funding opportunity directly with the sponsor before taking action. Trialect cannot be held liable for any discrepancies, omissions, or inaccuracies in third-party postings.
Notice and Takedown Policy: Trialect is committed to upholding copyright law and protecting the rights of intellectual property owners. If you believe that content on GrantsBoard infringes your copyright or intellectual property rights, please contact us with detailed information about the claim. Upon receipt of a valid notice, Trialect will promptly investigate and, where appropriate, remove or disable access to the infringing content.
Mar 26, 2026
Mar 26, 2026
$134,000
Affiliation: Cancer Research UK
Address: 2 Redman Place, London, E20 1JQ.
Disclaimer:It is mandatory that all applicants carry workplace liability insurance, e.g., https://www.protrip-world-liability.com (Erasmus students use this package and typically costs around 5 € per month - please check) in addition to health insurance when you join any of the onsite Trialect partnered fellowships.